Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting

被引:2
作者
Sharma, Sonali [1 ]
Khudiwal, Ashish [1 ]
Bhardwaj, Sonal [1 ]
Chaturvedi, Hemant [2 ]
Gupta, Rajeev [2 ,3 ]
机构
[1] Rajasthan Univ Hlth Sci, RUHS Coll Med Sci, Dept Biochem, Jaipur, Rajasthan, India
[2] Eternal Heart Care Ctr & Res Inst, Dept Prevent Cardiol, Jaipur, Rajasthan, India
[3] Rajasthan Univ Hlth Sci, Acad Res Dev Unit, Jaipur, Rajasthan, India
来源
PLOS ONE | 2022年 / 17卷 / 06期
关键词
POPULATION-PREVALENCE; PREVENTION; MANAGEMENT; DISEASE;
D O I
10.1371/journal.pone.0269605
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background & objective Heterozygous familial hypercholesterolemia (FHeH) is important risk factor for premature coronary artery disease (CAD). Strategies for its diagnosis and prevalence have not been well studied in India. We performed healthcare worker-based opportunistic screening to assess feasibility for determining its prevalence. Methods A healthcare worker was trained in use of Dutch Lipid Clinic Network (DLCN) criteria for diagnosis of FHeH. Successive eligible individuals (n = 3000 of 3450 screened) presenting to biochemistry laboratories of two hospitals for blood lipid measurements were evaluated for FHeH. Cascade screening or genetic studies were not performed. Descriptive statistics are reported. Results We included 2549 participants (men 1870, women 679) not on statin therapy. Health worker screened 25-30 individuals/day in 6-10 minutes each. The mean age was 46.2 +/- 11y. Variables of DLCN criteria were more in women vs men: family history 51.1 vs 35.6%, past CAD 48.2 vs 20.1%, arcus cornealis 1.1 vs 0.3%, tendon xanthoma 0.3 vs 0.1%, and LDL cholesterol 190-249 mg/dl in 8.5 vs 2.4%, 250-329 mg/dl in 0.7 vs 0% and >= 330 mg/dl in 0.3 vs 0% (p<0.01). Definite FHeH (DLCN score >8) was in 15 (0.59%, frequency 1:170) and probable FHeH (score 6-8) in 87 (3.4%, frequency 1:29). The prevalence was significantly greater in women, age <50y and in those with hypertension, diabetes and known CAD. Conclusions Healthcare worker-led opportunistic screening for diagnosis of FHeH using DLCN criteria is feasible in low-resource settings. The results show significant prevalence of clinically detected definite and probable FHeH in the population studied.
引用
收藏
页数:10
相关论文
共 34 条
[1]   Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis [J].
Akioyamen, Leo E. ;
Genest, Jacques ;
Shan, Shubham D. ;
Reel, Rachel L. ;
Albaum, Jordan M. ;
Chu, Anna ;
Tu, Jack V. .
BMJ OPEN, 2017, 7 (09)
[2]  
[Anonymous], 2008, Task shifting: rational redistribution of tasks among health workforce teams
[3]  
[Anonymous], 2010, Global experience of community health workers for delivery of health related Millennium Development Goals: A systematic review, country case studies, and recommendations for integration into national health systems
[4]  
[Anonymous], 1998, FAM HYP REP 2 WHO CO
[5]   Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects [J].
Beheshti, Sabina O. ;
Madsen, Christian M. ;
Varbo, Anette ;
Nordestgaard, Birge G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (20) :2553-2566
[6]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964
[7]   Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel [J].
Boren, Jan ;
Chapman, M. John ;
Krauss, Ronald M. ;
Packard, Chris J. ;
Bentzon, Jacob F. ;
Binder, Christoph J. ;
Daemen, Mat J. ;
Demer, Linda L. ;
Hegele, Robert A. ;
Nicholls, Stephen J. ;
Nordestgaard, Brge G. ;
Watts, Gerald F. ;
Bruckert, Eric ;
Fazio, Sergio ;
Ference, Brian A. ;
Graham, Ian ;
Horton, Jay D. ;
Landmesser, Ulf ;
Laufs, Ulrich ;
Masana, Luis ;
Pasterkamp, Gerard ;
Raal, Frederick J. ;
Ray, Kausik K. ;
Schunkert, Heribert ;
Taskinen, Marja-Riitta ;
van de Sluis, Bart ;
Wiklund, Olov ;
Tokgozoglu, Lale ;
Catapano, Alberico L. ;
Ginsberg, Henry N. .
EUROPEAN HEART JOURNAL, 2020, 41 (24) :2313-+
[8]   Improving detection and management of familial hypercholesterolaemia in Australian general practice [J].
Brett, Tom ;
Chan, Dick C. ;
Radford, Jan ;
Heal, Clare ;
Gill, Gerard ;
Hespe, Charlotte ;
Vargas-Garcia, Cristian ;
Condon, Carmen ;
Sheil, Barbara ;
Li, Ian W. ;
Sullivan, David R. ;
Vickery, Alistair W. ;
Pang, Jing ;
Arnold-Reed, Diane E. ;
Watts, Gerald F. .
HEART, 2021, 107 (15) :1213-1219
[9]   Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia [J].
Campbell-Salome, Gemme ;
Jones, Laney K. ;
Masnick, Max F. ;
Walton, Nephi A. ;
Ahmed, Catherine D. ;
Buchanan, Adam H. ;
Brangan, Andrew ;
Esplin, Edward D. ;
Kann, David G. ;
Ladd, Ilene G. ;
Kelly, Melissa A. ;
Kindt, Iris ;
Kirchner, H. Lester ;
McGowan, Mary P. ;
McMinn, Megan N. ;
Morales, Ana ;
Myers, Kelly D. ;
Oetjens, Matthew T. ;
Rahm, Alanna Kulchak ;
Schmidlen, Tara J. ;
Sheldon, Amanda ;
Simmons, Emilie ;
Snir, Moran ;
Strande, Natasha T. ;
Walters, Nicole L. ;
Wilemon, Katherine ;
Williams, Marc S. ;
Gidding, Samuel S. ;
Sturm, Amy C. .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (01) :E003120
[10]   Application of a risk stratification tool for familial hypercholesterolaemia in primary care: an observational cross-sectional study in an unselected urban population [J].
Carvalho, Chris ;
Williams, Crystal ;
Raisi-Estabragh, Zahra ;
Rison, Stuart ;
Patel, Riyaz S. ;
Timmis, Adam ;
Robson, John .
HEART, 2021, 107 (15) :1220-1225